Neurizon Therapeutics (FRA:ECQ0) Gross-Profit-to-Asset % : 0.00% (As of Dec. 2024)

Neurizon Therapeutics Gross-Profit-to-Asset % Chart

Neurizon Therapeutics Semi-Annual Data
	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Jun24	Dec24
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															27.80	33.84	-	-	-

Competitive Comparison of Neurizon Therapeutics's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Neurizon Therapeutics's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neurizon Therapeutics's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neurizon Therapeutics's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Neurizon Therapeutics's Gross-Profit-to-Asset % falls into.

Neurizon Therapeutics Gross-Profit-to-Asset % Calculation

Neurizon Therapeutics's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Jun. 2005 is calculated as:

Neurizon Therapeutics's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Neurizon Therapeutics Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Neurizon Therapeutics's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurizon Therapeutics Business Description